19 Jul Dimension Inx
Caralynn Nowinski Collens, M.D., CEO
Oct. 12 | 11:15am | Rentschler ATMP Ballroom
Dimension Inx is disrupting the way we treat patients and restore healthy tissues and organs, using a proprietary biomaterials platform to design and develop 3D-printed tissue therapeutics. We architect regenerative microenvironments to give the body a blueprint to heal itself. Our materials-centric approach enables biofunctionality and manufacturability. We precisely tune our biomaterials to create clinical solutions not otherwise possible. We work shoulder-to-shoulder with biotech and medical device partners to help solve their most challenging materials problems, and internally develop medical products for various therapeutic applications ranging from insulin production to fertility preservation.